文献速递关节外科运动医学

髋关节镜治疗股骨髋臼撞击综合征合并全局性与孤立性外侧髋臼过度覆盖的中期结局

Intermediate-Term Outcomes of Hip Arthroscopy for Femoroacetabular Impingement Syndrome in Patients With Global Versus Isolated Lateral Acetabular Overcoverage.
PubMed 文献 · Am J Sports Med · 2024-01-01

前瞻性队列研究纳入94例因股骨髋臼撞击综合征(FAIS)行髋关节镜且随访至少5年的患者,按髋臼覆盖分为无过度覆盖、外侧过度覆盖和全局过度覆盖三组。三组再手术率无差异(28.9%、29.4%、31.8%,P=0.971),未失败者5年功能评分无差异;术后LCEA>40°、女性和较高BMI与较差的改良Harris髋关节评分相关。

要点

  • 至少5年随访时,全局、外侧及无髋臼过度覆盖三组再手术率无差异(P=0.971)。
  • 未失败患者中,三组5年功能结局无差异。
  • 术后LCEA>40°、女性及较高BMI与较差的改良Harris髋关节评分相关。

核心结论

  • 至少5年随访时,全局髋臼过度覆盖、区域外侧髋臼过度覆盖与正常髋臼覆盖患者的功能结局或再手术率无差异。
  • 只要实施适当的髋臼成形术,没有证据表明全局髋臼过度覆盖比其他FAIS亚型预后更差。

研究设计与样本

  • 队列研究,证据等级3。
  • 前瞻性队列研究中因FAIS行髋关节镜且随访至少5年的患者纳入分析,共94例,平均年龄41.9±14.2岁,平均随访6.1±0.9年。
  • 按髋臼覆盖分组:全局过度覆盖(LCEA≥40°且深髋臼)、外侧过度覆盖(LCEA≥40°且无深髋臼)、无过度覆盖(LCEA<40°)。

主要发现

  • 40.4%无髋臼过度覆盖,36.2%为外侧过度覆盖,23.4%为全局过度覆盖。
  • 因翻修关节镜或转为全髋关节置换再手术的比例:正常髋臼覆盖组28.9%,外侧过度覆盖组29.4%,全局过度覆盖组31.8%,组间P=0.971。
  • 在初次髋关节镜未失败的患者中,三组5年功能结局无差异。
  • 术后LCEA>40°(β=-13.3;95%CI,-24.1至-2.6;P=0.016)、女性(β=-14.5;95%CI,-22.7至-6.2;P=0.001)和较高体重指数(β=-1.9;95%CI,-2.8至-1.0;P<0.001)与较差的改良Harris髋关节评分中期髋关节功能相关。

临床怎么用

  • 原文结论指出,只要实施适当的髋臼成形术,没有证据表明全局髋臼过度覆盖比其他FAIS亚型预后更差。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous studies evaluating the outcomes of hip arthroscopy for patients with global acetabular overcoverage and focal superolateral acetabular overcoverage suffer from short-term follow-up and inconsistent radiographic criteria when defining these subpopulations of patients with femoroacetabular impingement syndrome (FAIS). PURPOSE: To evaluate the intermediate-term postoperative outcomes for patients with FAIS in the setting of global acetabular overcoverage, lateral acetabular overcoverage, and normal acetabular coverage. STUDY DESIGN: Cohort study; Level of evidence, 3. METHODS: Patients undergoing hip arthroscopy for FAIS were enrolled in a prospective cohort study, and those with a minimum follow-up of 5 years were included in this analysis. Patients were grouped based on type of acetabular coverage: global overcoverage (lateral center-edge angle [LCEA] ≥40°, with coxa profunda), lateral overcoverage (LCEA ≥40°, without coxa profunda), and no overcoverage (LCEA <40°). Functional outcomes (modified Harris Hip Score and Nonarthritic Hip Score) and failure of primary hip arthroscopy were compared between groups. RESULTS: In total, 94 patients (mean age, 41.9 ± 14.2 years) were included with a mean follow-up duration of 6.1 ± 0.9 years. Of these patients, 40.4% had no acetabular overcoverage, 36.2% had lateral overcoverage, and 23.4% had global overcoverage. There was no difference between groups with respect to percentage of patients who underwent reoperation for either revision arthroscopy or conversion to total hip arthroplasty (28.9% for the normal acetabular coverage group, 29.4% for the lateral overcoverage group, and 31.8% for the global overcoverage group; P = .971). Among patients for whom primary hip arthroscopy did not fail, there was no difference in 5-year functional outcomes between groups. Postoperative LCEA >40° (β = -13.3; 95% CI, -24.1 to -2.6; P = .016), female sex (β = -14.5; 95% CI, -22.7 to -6.2; P = .001), and higher body mass index (β = -1.9; 95% CI, -2.8 to -1.0; P < .001) were associated with worse intermediate-term hip function in terms of modified Harris Hip Score. CONCLUSION: There was no difference in functional outcomes or rate of reoperation at a minimum of 5 years postoperatively between those with global acetabular overcoverage, those with regional lateral overcoverage, and those with normal acetabular coverage. Provided that an appropriate acetabuloplasty is performed, there is no evidence to suggest that global acetabular overcoverage portends a worse prognosis than other FAIS subtypes.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Kingery MT, Akpinar B, Rynecki ND, et al. Intermediate-Term Outcomes of Hip Arthroscopy for Femoroacetabular Impingement Syndrome in Patients With Global Versus Isolated Lateral Acetabular Overcoverage. Am J Sports Med. 2024. PMID: 38164680. doi:10.1177/03635465231213236

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。